Biodesix, Inc. BDSX Payments For Proceeds From Patent Costs And Intangible Asset Acquisition Net
Payments For Proceeds From Patent Costs And Intangible Asset Acquisition Net at other companies
Other financials
Where this comes from
Reported directly by Biodesix, Inc. in its filing.
Tagged under the XBRL concept bdsx:PaymentsForProceedsFromPatentCostsAndIntangibleAssetAcquisitionNet.
The official record: Biodesix, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Biodesix, Inc.'s payments for proceeds from patent costs and intangible asset acquisition net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Biodesix, Inc.'s payments for proceeds from patent costs and intangible asset acquisition net?
- Biodesix, Inc. (BDSX) reported payments for proceeds from patent costs and intangible asset acquisition net of $63K in Q1 2026.
- How has Biodesix, Inc.'s payments for proceeds from patent costs and intangible asset acquisition net changed year-over-year?
- Biodesix, Inc.'s payments for proceeds from patent costs and intangible asset acquisition net decreased by 0.0% year-over-year, from $63K to $63K.
- What is the long-term trend for Biodesix, Inc.'s payments for proceeds from patent costs and intangible asset acquisition net?
- Over 4 years (2021 to 2025), Biodesix, Inc.'s payments for proceeds from patent costs and intangible asset acquisition net has grown at a -17.2% compound annual growth rate (CAGR), from $306K to $144K.
- What does payments for proceeds from patent costs and intangible asset acquisition net mean?
- This represents the net cash outflow or inflow related to the acquisition, development, or disposal of intangible assets, including patent filings and intellectual property rights. For technology and diagnostic companies, this reflects the level of investment in protecting and expanding the company's competitive moat. It is a vital indicator of the company's commitment to long-term innovation and R&D protection.